Travere Therapeutics (TVTX) Property, Plant & Equipment (Net) Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.88% |
| Dec 31, 2025 | -15.65% |
| Sep 30, 2025 | -5.38% |
| Jun 30, 2025 | 9.25% |
| Mar 31, 2025 | 13.15% |
| Dec 31, 2024 | 13.04% |
| Sep 30, 2024 | 16.19% |
| Jun 30, 2024 | 16.89% |
| Mar 31, 2024 | 18.31% |
| Dec 31, 2023 | 18.91% |
| Sep 30, 2023 | 19.20% |
| Jun 30, 2023 | 19.92% |
| Mar 31, 2023 | 24.58% |
| Dec 31, 2022 | 22.88% |
| Sep 30, 2022 | 28.60% |
| Jun 30, 2022 | 31.74% |
| Mar 31, 2022 | 34.29% |
| Dec 31, 2021 | 33.83% |
| Sep 30, 2021 | 97.62% |
| Jun 30, 2021 | 98.43% |
| Mar 31, 2021 | 94.80% |
| Dec 31, 2020 | 85.57% |
| Sep 30, 2020 | 64.15% |
| Jun 30, 2020 | 41.92% |
| Mar 31, 2020 | 33.44% |
| Dec 31, 2019 | 33.93% |
| Sep 30, 2019 | 35.67% |
| Dec 31, 2018 | 89.89% |
| Sep 30, 2018 | 143.98% |
| Mar 31, 2018 | 154.63% |